The Prevalence of Sympathetic Overactivity in Primary Hypertensive Patients. (SORT)
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government.
Read our disclaimer for details.
Prevalence of SO in newly diagnosed hypertensive patients [ Time Frame: Visit 1-3: heart rate & Blood pressure, treatment presribed by physician. The interval between visit 1 and visit 2 is upto 4 weeks and interval between visit 2 & visit 3 is upto 4 weeks depending on Investigators discretion. ]
Secondary Outcome Measures
Association of SO and heart rate. [ Time Frame: Visits 1-3 ]
Subjective symptoms noticed by the doctor. [ Time Frame: 1st visit ]
To record the drugs used in the treatment of patients diagnosed with hypertension. [ Time Frame: Visits 1-3 ]
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study:
18 Years and older (Adult, Senior)
Sexes Eligible for Study:
Accepts Healthy Volunteers:
Primary hypertensive patients
Newly diagnosed essential hypertension patients will be eligible for the study.
Average of two or more systolic BP readings ≥ 140mmHg or diastolic BP readings ≥ 90mmHg